Clinicians & Researchers

You are here

Home

PETAL Network Bibliography

Export 57 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is R  [Clear All Filters]
2023
Shapiro NI, Douglas IS, Brower RG, Brown SM, Exline MC, Ginde AA, Gong MN, Grissom CK, Hayden D, Hough CL et al..  2023.  Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension.. N Engl J Med.
Shapiro NI, Douglas IS, Brower RG, Brown SM, Exline MC, Ginde AA, Gong MN, Grissom CK, Hayden D, Hough CL et al..  2023.  Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension.. N Engl J Med.
Berger JS, Neal MD, Kornblith LZ, Gong MN, Reynolds HR, Cushman M, Althouse AD, Lawler PR, McVerry BJ, Kim KS et al..  2023.  Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial.. JAMA Netw Open. 6(5):e2314428.
Self WH, Shotwell MS, Gibbs KW, de Wit M, D Files C, Harkins M, Hudock KM, Merck LH, Moskowitz A, Apodaca KD et al..  2023.  Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials.. JAMA. 329(14):1170-1182.
Self WH, Shotwell MS, Gibbs KW, de Wit M, D Files C, Harkins M, Hudock KM, Merck LH, Moskowitz A, Apodaca KD et al..  2023.  Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials.. JAMA. 329(14):1170-1182.
Gill JKaur, Day J, Renaud S.  2023.  Research Staff COVID-19 Pandemic Survey-Results from the Prevention and Early Treatment of Acute Lung Injury (PETAL) Network. COVID and Post-COVID: The Psychological and Social Impact of COVID-19. 3:1528-1543.
2022
Rogers AJ, Wentworth D, Phillips A, Shaw-Saliba K, Dewar RL, Aggarwal NR, Babiker AG, Dharan NJ, Davey VJ, Higgs ES et al..  2022.  The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19.. Ann Intern Med. 175(10):1401-1410.
Rogers AJ, Wentworth D, Phillips A, Shaw-Saliba K, Dewar RL, Aggarwal NR, Babiker AG, Dharan NJ, Davey VJ, Higgs ES et al..  2022.  The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19.. Ann Intern Med. 175(10):1401-1410.
Rogers AJ, Wentworth D, Phillips A, Shaw-Saliba K, Dewar RL, Aggarwal NR, Babiker AG, Dharan NJ, Davey VJ, Higgs ES et al..  2022.  The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19.. Ann Intern Med. 175(10):1401-1410.
Palakshappa JA, Russell GB, Gibbs KW, Kloefkorn C, Hayden D, Moss M, Hough CL, D Files C.  2022.  Association of early sedation level with patient outcomes in moderate-to-severe acute respiratory distress syndrome: Propensity-score matched analysis.. J Crit Care. 71:154118.
Peltan ID, Caldwell E, Admon AJ, Attia EF, Gundel SJ, Mathews KS, Nagrebetsky A, Sahetya SK, Ulysse C, Brown SM et al..  2022.  Characteristics and Outcomes of US Patients Hospitalized With COVID-19. Am J Crit Care. 31(2):146-157.
Peltan ID, Caldwell E, Admon AJ, Attia EF, Gundel SJ, Mathews KS, Nagrebetsky A, Sahetya SK, Ulysse C, Brown SM et al..  2022.  Characteristics and Outcomes of US Patients Hospitalized With COVID-19. Am J Crit Care. 31(2):146-157.
Berger JS, Kornblith LZ, Gong MN, Reynolds HR, Cushman M, Cheng Y, McVerry BJ, Kim KS, Lopes RD, Atassi B et al..  2022.  Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.. JAMA. 327(3):227-236.
Barkauskas C, Mylonakis E, Poulakou G, Young BE, Vock DM, Siegel L, Engen N, Grandits G, Mosaly NR, Vekstein AM et al..  2022.  Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.. Ann Intern Med. 175(9):1266-1274.
Barkauskas C, Mylonakis E, Poulakou G, Young BE, Vock DM, Siegel L, Engen N, Grandits G, Mosaly NR, Vekstein AM et al..  2022.  Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.. Ann Intern Med. 175(9):1266-1274.
Barkauskas C, Mylonakis E, Poulakou G, Young BE, Vock DM, Siegel L, Engen N, Grandits G, Mosaly NR, Vekstein AM et al..  2022.  Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.. Ann Intern Med. 175(9):1266-1274.
Barkauskas C, Mylonakis E, Poulakou G, Young BE, Vock DM, Siegel L, Engen N, Grandits G, Mosaly NR, Vekstein AM et al..  2022.  Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.. Ann Intern Med. 175(9):1266-1274.
Barkauskas C, Mylonakis E, Poulakou G, Young BE, Vock DM, Siegel L, Engen N, Grandits G, Mosaly NR, Vekstein AM et al..  2022.  Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.. Ann Intern Med. 175(9):1266-1274.
Barkauskas C, Mylonakis E, Poulakou G, Young BE, Vock DM, Siegel L, Engen N, Grandits G, Mosaly NR, Vekstein AM et al..  2022.  Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.. Ann Intern Med. 175(9):1266-1274.
Barkauskas C, Mylonakis E, Poulakou G, Young BE, Vock DM, Siegel L, Engen N, Grandits G, Mosaly NR, Vekstein AM et al..  2022.  Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.. Ann Intern Med. 175(9):1266-1274.
Mayer KP, Palakshappa JA, Peltan IDaniel, Andrew JS, Gundel SJ, Ringwood NJ, Mckeehan J, Hope AA, Rogers AJ, Biehl M et al..  2022.  Functional, imaging, and respiratory evaluation (FIRE) of patients post-hospitalization for COVID-19: protocol for a pilot observational study.. Pilot Feasibility Stud. 8(1):212.
Mayer KP, Palakshappa JA, Peltan IDaniel, Andrew JS, Gundel SJ, Ringwood NJ, Mckeehan J, Hope AA, Rogers AJ, Biehl M et al..  2022.  Functional, imaging, and respiratory evaluation (FIRE) of patients post-hospitalization for COVID-19: protocol for a pilot observational study.. Pilot Feasibility Stud. 8(1):212.
2021
Peltan ID, Caldwell E, Admon AJ, Attia EF, Gundel SJ, Mathews KS, Nagrebetsky A, Sahetya SK, Ulysse C, Brown SM et al..  2021.  Characteristics and Outcomes of US Patients Hospitalized With COVID-19. American Journal of Critical Care.
Peltan ID, Caldwell E, Admon AJ, Attia EF, Gundel SJ, Mathews KS, Nagrebetsky A, Sahetya SK, Ulysse C, Brown SM et al..  2021.  Characteristics and Outcomes of US Patients Hospitalized With COVID-19. American Journal of Critical Care.
Han JH, Ginde AA, Brown SM, Baughman A, Collar EM, E Ely W, Gong MN, Hope AA, Hou PC, Hough CL et al..  2021.  Effect of Early High-Dose Vitamin D3 Repletion on Cognitive Outcomes in Critically Ill Adults.. Chest. 160(3):909-918.
Han JH, Ginde AA, Brown SM, Baughman A, Collar EM, E Ely W, Gong MN, Hope AA, Hou PC, Hough CL et al..  2021.  Effect of Early High-Dose Vitamin D3 Repletion on Cognitive Outcomes in Critically Ill Adults.. Chest. 160(3):909-918.
Han JH, Ginde AA, Brown SM, Baughman A, Collar EM, E Ely W, Gong MN, Hope AA, Hou PC, Hough CL et al..  2021.  Effect of Early High-Dose Vitamin D3 Repletion on Cognitive Outcomes in Critically Ill Adults.. Chest. 160(3):909-918.
Lundgren JD, Grund B, Barkauskas CE, Holland TL, Gottlieb RL, Sandkovsky U, Brown SM, Knowlton KU, Self WH, D Files C et al..  2021.  A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.. N Engl J Med. 384(10):905-914.
Goligher EC, Bradbury CA, McVerry BJ, Lawler PR, Berger JS, Gong MN, Carrier M, Reynolds HR, Kumar A, Turgeon AF et al..  2021.  Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.. N Engl J Med. 385(9):777-789.
Goligher EC, Bradbury CA, McVerry BJ, Lawler PR, Berger JS, Gong MN, Carrier M, Reynolds HR, Kumar A, Turgeon AF et al..  2021.  Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.. N Engl J Med. 385(9):777-789.
Goligher EC, Bradbury CA, McVerry BJ, Lawler PR, Berger JS, Gong MN, Carrier M, Reynolds HR, Kumar A, Turgeon AF et al..  2021.  Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.. N Engl J Med. 385(9):777-789.
Goligher EC, Bradbury CA, McVerry BJ, Lawler PR, Berger JS, Gong MN, Carrier M, Reynolds HR, Kumar A, Turgeon AF et al..  2021.  Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.. N Engl J Med. 385(9):777-789.
Goligher EC, Bradbury CA, McVerry BJ, Lawler PR, Berger JS, Gong MN, Carrier M, Reynolds HR, Kumar A, Turgeon AF et al..  2021.  Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.. N Engl J Med. 385(9):777-789.
Lawler PR, Goligher EC, Berger JS, Neal MD, McVerry BJ, Nicolau JC, Gong MN, Carrier M, Rosenson RS, Reynolds HR et al..  2021.  Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.. N Engl J Med. 385(9):790-802.
Lawler PR, Goligher EC, Berger JS, Neal MD, McVerry BJ, Nicolau JC, Gong MN, Carrier M, Rosenson RS, Reynolds HR et al..  2021.  Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.. N Engl J Med. 385(9):790-802.
Lawler PR, Goligher EC, Berger JS, Neal MD, McVerry BJ, Nicolau JC, Gong MN, Carrier M, Rosenson RS, Reynolds HR et al..  2021.  Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.. N Engl J Med. 385(9):790-802.
Lawler PR, Goligher EC, Berger JS, Neal MD, McVerry BJ, Nicolau JC, Gong MN, Carrier M, Rosenson RS, Reynolds HR et al..  2021.  Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.. N Engl J Med. 385(9):790-802.
Lawler PR, Goligher EC, Berger JS, Neal MD, McVerry BJ, Nicolau JC, Gong MN, Carrier M, Rosenson RS, Reynolds HR et al..  2021.  Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.. N Engl J Med. 385(9):790-802.
2020
Self WH, Semler MW, Leither LM, Casey JD, Angus DC, Brower RG, Chang SY, Collins SP, Eppensteiner JC, Filbin MR et al..  2020.  Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial . JAMA.
Self WH, Semler MW, Leither LM, Casey JD, Angus DC, Brower RG, Chang SY, Collins SP, Eppensteiner JC, Filbin MR et al..  2020.  Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial . JAMA.
Baron RM, Christman JW, Liu KD, Matthay MA, Self WH, McVerry BJ, Hite RDuncan, Paine R, Wurfel MM, Shapiro NI et al..  2020.  Monitoring Research Blood Sampling in Critically Ill Patients: Avoiding Iatrogenic Anemia.. Am J Respir Crit Care Med. 202(6):885-887.
Casey JD, Johnson NJ, Semler MW, Collins SP, Aggarwal NR, Brower RG, Chang SY, Eppensteiner J, Filbin M, Gibbs KW et al..  2020.  Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19.. Ann Am Thorac Soc. 17(9):1144-1153.
Casey JD, Johnson NJ, Semler MW, Collins SP, Aggarwal NR, Brower RG, Chang SY, Eppensteiner J, Filbin M, Gibbs KW et al..  2020.  Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19.. Ann Am Thorac Soc. 17(9):1144-1153.
Casey JD, Johnson NJ, Semler MW, Collins SP, Aggarwal NR, Brower RG, Chang SY, Eppensteiner J, Filbin M, Gibbs KW et al..  2020.  Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19.. Ann Am Thorac Soc. 17(9):1144-1153.
Casey JD, Johnson NJ, Semler MW, Collins SP, Aggarwal NR, Brower RG, Chang SY, Eppensteiner J, Filbin M, Gibbs KW et al..  2020.  Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19.. Ann Am Thorac Soc. 17(9):1144-1153.
2019
Ginde AA, Brower RG, Caterino JM, Finck L, Banner-Goodspeed VM, Grissom CK, Hayden D, Hough CL, Hyzy RC, Khan A et al..  2019.  Early High-Dose Vitamin D for Critically Ill, Vitamin D-Deficient Patients.. N Engl J Med. 381(26):2529-2540.
Ginde AA, Brower RG, Caterino JM, Finck L, Banner-Goodspeed VM, Grissom CK, Hayden D, Hough CL, Hyzy RC, Khan A et al..  2019.  Early High-Dose Vitamin D for Critically Ill, Vitamin D-Deficient Patients.. N Engl J Med. 381(26):2529-2540.
2018
Self WH, Semler MW, Bellomo R, Brown SM, deBoisblanc BP, Exline MC, Ginde AA, Grissom CK, Janz DR, Jones AE et al..  2018.  Liberal Versus Restrictive Intravenous Fluid Therapy for Early Septic Shock: Rationale for a Randomized Trial.. Ann Emerg Med. 72(4):457-466.
Self WH, Semler MW, Bellomo R, Brown SM, deBoisblanc BP, Exline MC, Ginde AA, Grissom CK, Janz DR, Jones AE et al..  2018.  Liberal Versus Restrictive Intravenous Fluid Therapy for Early Septic Shock: Rationale for a Randomized Trial.. Ann Emerg Med. 72(4):457-466.
2017
Brown SM, Duggal A, Tidswell M, Khan A, Exline M, Park PK, Schoenfeld DS, Liu M, Grissom CK, Moss M et al..  2017.  Nonlinear Imputation of PaO2/FIO2 From SpO2/FIO2 Among Mechanically Ventilated Patients in the ICU: A Prospective, Observational Study.. Critical Care Medicine. 45(8):1317-1324.

Pages